瑞慈医疗(01526.HK)中期亏损收窄11.25%至6024.1万元
格隆汇8月31日丨瑞慈医疗(01526.HK)公布,截至2019年6月30日止中期,实现收入人民币7.03亿元(单位下同),同比增长28.68%;毛利1.51亿元,同比增长46.29%;公司拥有人应占期内亏损6024.1万元,同比收窄11.25%;每股亏损0.04元。
收益增加主要由于综合医院业务、体检业务及专科医院业务收入均实现增长。期内亏损主要是由于处于营运初期的新体检中心及专科医院产生较多亏损,及采纳香港财务报告准则第16号的影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.